Geovax Labs Inc
General ticker "GOVX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $15.9M
Geovax Labs Inc does not follow the US Stock Market performance with the rate: -3.5%.
Estimated limits based on current volatility of 3.4%: low 2.17$, high 2.32$
Factors to consider:
- Current price 28.6% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.17$, 9.20$]
- 2024-12-30 to 2025-12-30 estimated range: [2.78$, 7.82$]
Financial Metrics affecting the GOVX estimates:
- Negative: Non-GAAP EPS, $ of -23.95 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -64.21 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term GOVX quotes
Long-term GOVX plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.39MM | $0.08MM | $0.00MM |
Operating Expenses | $19.13MM | $14.11MM | $26.74MM |
Operating Income | $-18.75MM | $-14.03MM | $-26.74MM |
Non-Operating Income | $0.18MM | $0.01MM | $0.78MM |
Interest Expense | $0.00MM | $0.00MM | $0.00MM |
R&D Expense | $15.55MM | $9.12MM | $20.72MM |
Income(Loss) | $-18.57MM | $-14.02MM | $-25.97MM |
Profit(Loss) | $-18.57MM | $-14.02MM | $-25.97MM |
Stockholders Equity | $4.36MM | $26.60MM | $5.76MM |
Inventory | $0.05MM | $0.00MM | $0.00MM |
Assets | $11.80MM | $31.35MM | $9.28MM |
Operating Cash Flow | $-11.20MM | $-19.03MM | $-25.17MM |
Capital expenditure | $0.05MM | $0.13MM | $0.05MM |
Investing Cash Flow | $-0.05MM | $-0.13MM | $-0.05MM |
Financing Cash Flow | $12.78MM | $35.35MM | $4.06MM |
Earnings Per Share* | $-7.30 | $-5.52 | $-10.22 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.